Therapy-Induced Senescence in Cancer

Jonathan A. Ewald(Broad Institute), David F. Jarrard(University of Wisconsin System)

JNCI Journal of the National Cancer Institute

September 22, 2010

10.1093/jnci/djq364

Cited by 822

Related Papers

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

|New England Journal of Medicine|2015|2.8k

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

|Journal of Clinical Oncology|2018|1.1k

Overexpression of the Novel Senescence Marker β-Galactosidase (GLB1) in Prostate Cancer Predicts Reduced PSA Recurrence

|PLoS ONE|2015|80

Persistence of senescent prostate cancer cells following prolonged neoadjuvant androgen deprivation therapy

|PLoS ONE|2017|34